Related Experiment Video
Updated: Feb 13, 2026

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
Published on: March 13, 2013
A putative role for Discoidin Domain Receptor 1 in cancer chemoresistance
Chiara Ambrogio1, Elodie Darbo2, Sam W Lee3
1a Department of Medical Oncology , Dana-Farber Cancer Institute , Boston , MA , USA.
Abstract:
The Discoidin Domain Receptor 1 (DDR1) receptor tyrosine kinase performs pleiotropic functions in the control of cell adhesion, proliferation, survival, migration, and invasion. Aberrant DDR1 function as a consequence of either mutations or increased expression has been associated with various human diseases including cancer. Pharmacological inhibition of DDR1 results in significant therapeutic benefit in several pre-clinical cancer models. Here, we discuss the potential implication of DDR1-dependent pro-survival functions in the development of cancer resistance to chemotherapeutic regimens and speculate on the molecular mechanisms that might mediate such important feature.
Insights
Discoidin Domain Receptor 1 (DDR1) promotes cancer cell survival, potentially causing resistance to chemotherapy. Inhibiting DDR1 may offer therapeutic benefits in cancer treatment by overcoming this resistance.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Discoidin Domain Receptor 1 (DDR1) is a receptor tyrosine kinase involved in cell adhesion, proliferation, survival, migration, and invasion.
- Dysregulation of DDR1, through mutations or overexpression, is linked to human diseases, notably cancer.
Purpose of the Study:
- To explore the role of DDR1-dependent pro-survival functions in the development of cancer resistance to chemotherapy.
- To speculate on the molecular mechanisms underlying DDR1's contribution to chemoresistance.
Main Methods:
- Literature review and discussion of existing pre-clinical data.
- Analysis of DDR1's known functions in cell signaling pathways.
- Hypothesizing molecular mechanisms of DDR1-mediated chemoresistance.
Main Results:
- Pharmacological inhibition of DDR1 has shown therapeutic benefits in pre-clinical cancer models.
- DDR1's pro-survival signaling may contribute to cancer cells evading chemotherapeutic agents.
- Specific molecular pathways mediating DDR1's role in chemoresistance are proposed.
Conclusions:
- DDR1 plays a significant role in promoting cancer cell survival.
- Targeting DDR1 presents a potential strategy to overcome chemoresistance in cancer therapy.
- Further research into DDR1's molecular mechanisms is warranted to develop effective anti-cancer treatments.
Related Concept Videos
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Three Developmental Domains
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
Membrane Domains
Protein Domains
The membrane comprises a group of distinct proteins responsible for carrying out a cell's specific function. For example, the plasma membrane of the human sperm, or a single germ cell, contains a unique set of proteins in the...
Three-Domain System of Life
Internal Receptors

